San Diego, CA, United States of America

Steven L Roach



 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • San Deigo, CA (US) (2018)
  • San Diego, CA (US) (2014 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Steven L Roach: A Leader in Granulocyte Colony-Stimulating Factor Research

Introduction: Steven L Roach, based in San Diego, CA, is a notable inventor with a significant contribution to the field of medical science. With a total of seven patents to his name, Roach has made substantial advancements in the understanding and application of granulocyte colony-stimulating factor receptor (GCFR) technologies. His innovative work is paving the way for new treatment options for various disorders.

Latest Patents: Among his latest patents, Roach has developed several methods and compositions associated with the granulocyte colony-stimulating factor receptor. These inventions focus on compositions and methods for identifying compounds that modulate the activity of GCFR. In particular, some embodiments relate to using these compounds to treat disorders such as hematopoietic or neurological conditions, showcasing his commitment to addressing critical health challenges.

Career Highlights: Steven L Roach is currently affiliated with Ligand Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical inventions. His work not only demonstrates his innovative spirit but also highlights the importance of collaboration within the research community to drive meaningful advancements in medicine.

Collaborations: Throughout his career, Roach has collaborated with talented colleagues, including Lin Zhi and Andrew Richard Hudson. These partnerships underline the collaborative nature of innovation in science, where diverse teams contribute their unique skills to tackle complex problems effectively.

Conclusion: Steven L Roach is a prominent figure in the invention of methodologies linked to the granulocyte colony-stimulating factor receptor. His seven patents reflect his innovative contributions to medical science and his dedication to improving treatment options for patients. As he continues his work at Ligand Pharmaceuticals, his research promises to have a lasting impact on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…